Thank God.
One of the subjects of the recent national media coverage of patients making their own drug trials told me, "The FDA needs to reassess its policy with regards to ALS. It is a unique disease and requires unique FDA policies."
Are we designing and pursuing change that will make a difference for those with the disease like no other?
No comments:
Post a Comment